Treatment Considerations in HR+/HER2- eBC from ASCO 2023
Penn Medicine Updates in Oncology 2023: Adjuvant CDK4/6i for Breast Cancer
By
Penn Medicine Abramson Cancer Center
FEATURING
Amy Clark
By
Penn Medicine Abramson Cancer Center
FEATURING
Amy Clark
Login to view comments.
Click here to Login
Treatment Considerations in HR+/HER2- eBC from ASCO 2023